Gökben Baskaynak - Concepedia

Author

Gökben Baskaynak

Charité - Universitätsmedizin Berlin

Also Known As

G Baskaynak, G. Baskaynak, Gokben Baskaynak, Gökben Baskaynak, Gökben Baskaynak

Publications

592

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Humboldt-Universität zu Berlin University Hospital Carl Gustav Carus

About

Gökben Baskaynak is an author at Charité - Universitätsmedizin Berlin specializing in cell biology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	308
2	Cell Biology	4	4	369
3	Immunology	2	2	107
4	Natural Sciences	1	1	121
5	Molecular Biology	1	1	121

Gökben Baskaynak

Publications

566

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588 Philipp le Coutre, Karl‐Anton Kreuzer, Stefan Pursche, Cancer Chemotherapy and Pharmacology Physiologically-based Pharmacokinetic ModelingMedicineCellular UptakeMain Metabolite Cgp74588Cellular Pharmacology	2003	158
Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR Joachim Lupberger, Karl‐Anton Kreuzer, Gökben Baskaynak, Molecular and Cellular Probes Porphobilinogen Deaminase MrnaSystems BiologyProtein ExpressionControl TranscriptsNatural Sciences	2002	121
Imatinib‐induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukemia Michaela Schwarz, Karl‐Anton Kreuzer, Gökben Baskaynak, European Journal Of Haematology ImmunologyPathologyExanthematous PustulosisDermatologyImmunotherapy	2002	60
Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia Urban Novak, Tobias Grob, Gökben Baskaynak, Annals of Oncology Hematological MalignancyNovel FindingP73 GeneMixed-phenotype Acute LeukemiaImmunology	2001	47
Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis. U Peters, Mario P. Tschan, Karl‐Anton Kreuzer, PubMed Mixed-phenotype Acute LeukemiaPathologyCancer BiologyTumor BiologyMyeloid Neoplasia	1999	43
Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment Gökben Baskaynak, Karl‐Anton Kreuzer, Michaela Schwarz, European Journal Of Haematology	2003	43
Vaccination with autologous non‐irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia Jörg Westermann, Joachim Kopp, Antje van Lessen, British Journal of Haematology	2007	40
Filgrastim‐induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient <i>in vivo</i> purging Karl‐Anton Kreuzer, Christine Klühs, Gökben Baskaynak, British Journal of Haematology	2003	28
Imatinib in Philadelphia chromosome‐positive chronic phase CML patients: Molecular and cytogenetic response rates and prediction of clinical outcome Philipp le Coutre, Karl‐Anton Kreuzer, Il‐Kang Na, American Journal of Hematology	2003	14
Activity and Induction of Apoptosis of the Specific Tyrosine Kinase Inhibitor AMN 107 in bcr-abl + Cell Lines and in Imatinib Resistant Primary Cells from CML Patients. Philipp le Coutre, Gökben Baskaynak, Ingo Tamm, Blood	2004	12

Page 1